⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATOS News
Atossa Therapeutics, Inc. Common Stock
Eviden IAM Awarded the Cybersecurity Made In Europe Label from the European Cyber Security Organisation, ECSO
globenewswire.com
ATOS
Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update
prnewswire.com
ATOS
Form 8-K
sec.gov
ATOS
Atos Unveils its Leading-Edge Services to CONMEBOL at the CONMEBOL Libertadores and CONMEBOL Sudamericana Competition Draws
globenewswire.com
ATOS
Middle East and Africa (MEA) IT Services Market 2026-2031: A $387 Billion Opportunity Led by Accenture, IBM, Oracle
globenewswire.com
ACN
IBM
ORCL
MSFT
AMZN
SAP
INFY
GOOGL
MNDO
ATOS
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
globenewswire.com
ATOS
ONCY
SNSE
TNGX
OSTX
Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
prnewswire.com
ATOS
Rare Disease Campaign Launches Nationwide
prnewswire.com
ATOS
Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference
prnewswire.com
ATOS
Atos Group Launches Sovereign Agentic Studios to Bring AI Safely into Production Across Organizations
globenewswire.com
ATOS